Neurotrope, Inc. Common
NTRP
NTRP was delisted on the 1st of December, 2020.
34 hedge funds and large institutions have $15.3M invested in Neurotrope, Inc. Common in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
61% more capital invested
Capital invested by funds: $9.53M → $15.3M (+$5.79M)
45% more call options, than puts
Call options by funds: $1.3M | Put options by funds: $894K
6% more funds holding
Funds holding: 32 → 34 (+2)
0% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
+$409K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$320K |
| 3 |
BCM
Bluefin Capital Management
New York
|
+$288K |
| 4 |
BlackRock
New York
|
+$238K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$231K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MA
MYDA Advisors
Woodmere,
New York
|
-$335K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$281K |
| 3 |
Renaissance Technologies
New York
|
-$141K |
| 4 |
PFO
Pathstone Family Office
Englewood,
New Jersey
|
-$121K |
| 5 |
Wolverine Trading
Chicago,
Illinois
|
-$46.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RJA
26
Raymond James & Associates
St Petersburg,
Florida
| $94K | – | – | – |
|
|
PAM
27
Panagora Asset Management
Boston,
Massachusetts
| $77K | -$11.1K | -1,656 | -15% |
|
28
Group One Trading
Chicago,
Illinois
| $69K | +$58.2K | +8,656 | New |
|
|
CG
29
Cutler Group
San Francisco,
California
| $54K | +$36.3K | +5,399 | +386% |
|
|
SPIA
30
Steward Partners Investment Advisory
New York
| $23K | +$19.5K | +2,898 | New |
|
31
UBS Group
Zurich,
Switzerland
| $18K | +$81 | +12 | +0.5% |
|
|
TRCT
32
Tower Research Capital (TRC)
New York
| $13K | -$18.8K | -2,799 | -64% |
|
33
Wells Fargo
San Francisco,
California
| $8K | – | – | – |
|
34
First Manhattan
New York
| $4K | – | – | – |
|
|
35
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$281K | -51,726 | Closed |
|
|
FIA
36
FNY Investment Advisers
New York
| – | -$11K | -2,114 | Closed |
|
NTRP Hedge Fund Activity: Q2 2019 in Review
34 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Neurotrope, Inc. Common (NTRP) for Q2 2019, worth a combined $15.3M — up 61% from $9.53M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new NTRP positions and 2 closed out — a net gain of 2 holders — while 10 added to existing stakes and 10 trimmed.
The largest buyer was Dimensional Fund Advisors, adding an estimated $409K. The largest seller was MYDA Advisors, cutting an estimated $335K.
- 34 institutional investors held Neurotrope, Inc. Common (NTRP) as of Q2 2019, up from 32 in Q1 2019.
- Funds reported $15.3M of Neurotrope, Inc. Common stock for Q2 2019, up 61% quarter-over-quarter.
- 4 funds opened new Neurotrope, Inc. Common positions in Q2 2019 and 2 closed out, a net change of +2 holders.
- The largest Neurotrope, Inc. Common buyer in Q2 2019 was Dimensional Fund Advisors, an estimated $409K added.
- The largest Neurotrope, Inc. Common seller in Q2 2019 was MYDA Advisors, an estimated $335K sold.
Based on aggregated 13F filings for Q2 2019.